Photo from wikipedia
We read with interest the study by Kumada et al entitled "Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis" recently published in the Journal… Click to show full abstract
We read with interest the study by Kumada et al entitled "Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis" recently published in the Journal of Viral Hepatitis1 . The authors found that use of nuleos(t)ide analogues in patients with HBV-related decompensated cirrhosis reduced liver-related mortality but not risk of hepatocarcinogenesis and non-liver-related mortality. Although we agree with the conclusions of this study, the following issue needs to be addressed.
Journal Title: Journal of Viral Hepatitis
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!